Top

Published in:

Open Access 01-12-2012 | Original Paper

Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS

Authors: Jigisha R. Patel, Jessica L. Williams, Megan M. Muccigrosso, Laindy Liu, Tao Sun, Joshua B. Rubin, Robyn S. Klein

Published in: Acta Neuropathologica | Issue 6/2012

Abstract

Multiple sclerosis (MS) is characterized by episodes of inflammatory demyelination with progressive failure of remyelination. Prior studies using murine models of MS indicate that remyelination within the adult central nervous system (CNS) requires the expression and activity of TNFR2 and CXCR4 by oligodendrocyte progenitor cells (OPCs), promoting their proliferation and differentiation into mature oligodendrocytes. Here, we extend these studies by examining the role of TNFR2 in the expression of the CXCR4 ligand, CXCL12, within the corpus callosum (CC) during cuprizone (CPZ) intoxication and by demonstrating that lentiviral-mediated gene delivery of CXCL12 to the demyelinated CC improves OPC proliferation and myelin expression during remyelination. Activated astrocytes and microglia express both TNFR1 and TNFR2 within the demyelinated CC. However, CPZ intoxicated TNFR2−/− mice exhibit loss of up-regulation of CXCL12 in astrocytes with concomitant decreases in numbers of CXCR4+ NG2+ OPCs within the CC. While CXCR4 antagonism does not affect OPC migration from subventricular zones into the CC, it decreases their proliferation and differentiation within the CC. Stereotactic delivery of lentivirus expressing CXCL12 protein into the CC of acutely demyelinated TNFR2−/− mice increases OPC proliferation and expression of myelin. In contrast, chronically demyelinated wild-type mice, which exhibit significant loss of astrocytes and OPCs, are unable to be rescued via CXCL12 lentivirus alone but instead required engraftment of CXCL12-expressing astrocytes for increased myelin expression. Our results show that TNFR2 activation induces CXCL12 expression in the demyelinated CC via autocrine signaling specifically within astrocytes, which promotes OPC proliferation and differentiation. In addition, gene delivery of critical pro-myelinating proteins might be a feasible approach for the treatment of remyelination failure in MS.

Available only for authorised users

Ambrosini E, Remoli ME, Giacomini E, Rosicarelli B, Serafini B, Lande R, Aloisi F, Coccia EM (2005) Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J Neuropathol Exp Neurol 64(8):706–715 pii:00005072-200508000-00007PubMedCrossRef

Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4(11):1116–1122. doi:10.1038/nn738 PubMedCrossRef

Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, Miller RJ (2011) The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol Dis 44(1):19–27. doi:10.1016/j.nbd.2011.05.019 PubMed

Barnhart BC, Peter ME (2003) The TNF receptor 1: a split personality complex. Cell 114(2):148–150 pii:S0092867403005610PubMedCrossRef

Biancotti JC, Kumar S, de Vellis J (2008) Activation of inflammatory response by a combination of growth factors in cuprizone-induced demyelinated brain leads to myelin repair. Neurochem Res 33(12):2615–2628. doi:10.1007/s11064-008-9792-8 PubMedCrossRef

Blaise S, Kneib M, Rousseau A, Gambino F, Chenard MP, Messadeq N, Muckenstrum M, Alpy F, Tomasetto C, Humeau Y, Rio MC (2012) In vivo evidence that TRAF4 is required for central nervous system myelin homeostasis. PLoS ONE 7(2):e30917. doi:10.1371/journal.pone.0030917 PubMedCrossRef

Blakemore WF, Gilson JM, Crang AJ (2003) The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp Neurol 184(2):955–963. doi:10.1016/S0014-4886(03)00347-9 PubMedCrossRef

Blakemore WF, Irvine KA (2008) Endogenous or exogenous oligodendrocytes for remyelination. J Neurol Sci 265(1–2):43–46. doi:S0022-510X(07)00533-310.1016/j.jns.2007.08.004 PubMedCrossRef

Bonizzi G, Bebien M, Otero DC, Johnson-Vroom KE, Cao Y, Vu D, Jegga AG, Aronow BJ, Ghosh G, Rickert RC, Karin M (2004) Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23(21):4202–4210. doi:10.1038/sj.emboj.7600391 PubMedCrossRef

10.

Carbajal KS, Miranda JL, Tsukamoto MR, Lane TE (2011) CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 59(12):1813–1821. doi:10.1002/glia.21225 PubMedCrossRef

11.

Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE (2010) Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 107(24):11068–11073. doi:10.1073/pnas.1006375107 PubMedCrossRef

12.

Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, McCandless EE, Patel JR, Luker GD, Littman DR, Russell JH, Klein RS (2011) CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med 208(2):327–339. doi:10.1084/jem.20102010 PubMedCrossRef

13.

Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF, Green DR (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4):525–535PubMedCrossRef

14.

Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M (2005) A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50(3):258–269. doi:10.1002/glia.20170 PubMedCrossRef

15.

Fischer R, Maier O, Siegemund M, Wajant H, Scheurich P, Pfizenmaier K (2011) A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death. PLoS ONE 6(11):e27621. doi:10.1371/journal.pone.0027621 PubMedCrossRef

16.

Franklin RJ, Crang AJ, Blakemore WF (1991) Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20(5):420–430PubMedCrossRef

17.

Gimenez MA, Sim J, Archambault AS, Klein RS, Russell JH (2006) A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. Am J Pathol 168(4):1200–1209 pii:168/4/1200PubMedCrossRef

18.

Glabinski AR, Bielecki B, Kolodziejski P, Han Y, Selmaj K, Ransohoff RM (2003) TNF-alpha microinjection upregulates chemokines and chemokine receptors in the central nervous system without inducing leukocyte infiltration. J Interferon Cytokine Res Official J Int Soc Interferon Cytokine Res 23(8):457–466. doi:10.1089/107999003322277874 CrossRef

19.

Gottle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Kury P (2010) Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 68(6):915–924. doi:10.1002/ana.22214 PubMedCrossRef

20.

Gregory-Evans K, Bashar AE, Tan M (2012) Ex vivo gene therapy and vision. Curr Gene Ther 12(2):103–115PubMedCrossRef

21.

Group TL (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53(3):457–465CrossRef

22.

Han Y, He T, Huang DR, Pardo CA, Ransohoff RM (2001) TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J Clin Invest 108(3):425–435. doi:10.1172/JCI12629 PubMed

23.

Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170(2):607–612PubMedCrossRef

24.

Jin J, Chang Y, Wei W (2010) Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis. Acta Pharmacol Sin 31(9):1133–1140. doi:aps201013410.1038/aps.2010.134 PubMedCrossRef

25.

Jung Y, Wang J, Schneider A, Sun YX, Koh-Paige AJ, Osman NI, McCauley LK, Taichman RS (2006) Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 38(4):497–508PubMedCrossRef

26.

Kew RR, Penzo M, Habiel DM, Marcu KB (2012) The IKKalpha-dependent NF-kappaB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J Immunol 188(5):2380–2386. doi:10.4049/jimmunol.1102454 PubMedCrossRef

27.

Kircik LH, Del Rosso JQ (2009) Anti-TNF agents for the treatment of psoriasis. J Drugs Dermatol 8(6):546–559PubMed

28.

Knapp PE, Adams MH (2004) Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury. Exp Cell Res 296(2):135–144. doi:10.1016/j.yexcr.2004.02.007S0014482704000801 PubMedCrossRef

29.

Liu L, Belkadi A, Darnall L, Hu T, Drescher C, Cotleur AC, Padovani-Claudio D, He T, Choi K, Lane TE, Miller RH, Ransohoff RM (2010) CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci 13(3):319–326. doi:10.1038/nn.2491 PubMedCrossRef

30.

Liu L, Darnall L, Hu T, Choi K, Lane TE, Ransohoff RM (2010) Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J Neurosci 30(27):9074–9083. doi:10.1523/JNEUROSCI.1238-10.2010 PubMed

31.

Maimone D, Gregory S, Arnason BG, Reder AT (1991) Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis. J Neuroimmunol 32(1):67–74 pii:0165-5728(91)90073-GPubMedCrossRef

32.

Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279(31):32869–32881. doi:10.1074/jbc.M311766200 PubMedCrossRef

33.

Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61(3):251–262. doi:10.1002/1097-4547(20000801)61:3<251:AID-JNR3>3.0.CO;2-W PubMedCrossRef

34.

Mason JL, Ye P, Suzuki K, D’Ercole AJ, Matsushima GK (2000) Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20(15):5703–5708 pii:20/15/5703PubMed

35.

Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11(1):107–116PubMedCrossRef

36.

McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS (2006) CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol 177(11):8053–8064 pii:177/11/8053PubMed

37.

McCandless EE, Zhang B, Diamond MS, Klein RS (2008) CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci USA 105(32):11270–11275. doi:10.1073/pnas.0800898105 PubMedCrossRef

38.

Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ (2011) How factors secreted from astrocytes impact myelin repair. J Neurosci Res 89(1):13–21. doi:10.1002/jnr.22482 PubMedCrossRef

39.

Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ (2011) Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci Off J Soc Neurosci 31(16):6247–6254. doi:10.1523/JNEUROSCI.5474-10.2011 CrossRef

40.

Nikolaus S, Schreiber S (2008) Anti-TNF biologics in the treatment of chronic inflammatory bowel disease. Internist (Berl) 49 (8):947–948, 950–943. doi:10.1007/s00108-008-2058-3

41.

Omari KM, Lutz SE, Santambrogio L, Lira SA, Raine CS (2009) Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol 174(1):164–176. doi:10.2353/ajpath.2009.080350 PubMedCrossRef

42.

Otto VI, Heinzel-Pleines UE, Gloor SM, Trentz O, Kossmann T, Morganti-Kossmann MC (2000) sICAM-1 and TNF-alpha induce MIP-2 with distinct kinetics in astrocytes and brain microvascular endothelial cells. J Neurosci Res 60(6):733–742PubMedCrossRef

43.

Patel JR, McCandless EE, Dorsey D, Klein RS (2010) CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 107(24):11062–11067. doi:100630110710.1073/pnas.1006301107 PubMedCrossRef

44.

Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Academic Press, San Diego

45.

Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Nat Acad Sci USA 92(24):11294–11298PubMedCrossRef

46.

Selmaj K, Raine CS, Cross AH (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30(5):694–700. doi:10.1002/ana.410300510 PubMedCrossRef

47.

Selmaj KW, Raine CS (1995) Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45(6 Suppl 6):S44–S49PubMedCrossRef

48.

Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325(7):467–472. doi:10.1056/NEJM199108153250704 PubMedCrossRef

49.

Smit AB, Syed NI, Schaap D, van Minnen J, Klumperman J, Kits KS, Lodder H, van der Schors RC, van Elk R, Sorgedrager B, Brejc K, Sixma TK, Geraerts WP (2001) A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411(6835):261–268. doi:10.1038/35077000 PubMedCrossRef

50.

Sun T, Gianino SM, Jackson E, Piwnica-Worms D, Gutmann DH, Rubin JB (2010) CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice. J Neuroimmunol 224(1–2):108–113. doi:10.1016/j.jneuroim.2010.05.002 PubMedCrossRef

51.

Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L (2008) TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Nat Acad Sci USA 105(16):6185–6190. doi:10.1073/pnas.0801447105 PubMedCrossRef

52.

Tsai HH, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, Ransohoff RM, Miller RH (2002) The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110(3):373–383 pii:S0092867402008383PubMedCrossRef

53.

Ullian EM, Sapperstein SK, Christopherson KS, Barres BA (2001) Control of synapse number by glia. Science 291(5504):657–661. doi:10.1126/science.291.5504.657 PubMedCrossRef

54.

Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL (2011) Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci Off J Soc Neurosci 31(16):6053–6058. doi:10.1523/JNEUROSCI.5524-09.2011 CrossRef

55.

Wang Y, Luo W, Reiser G (2007) The role of calcium in protease-activated receptor-induced secretion of chemokine GRO/CINC-1 in rat brain astrocytes. J Neurochem 103(2):814–819. doi:10.1111/j.1471-4159.2007.04803.x PubMedCrossRef

56.

Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65(3):239–248. doi:10.1002/ana.21640 PubMedCrossRef

57.

Zhao C, Strappe PM, Lever AM, Franklin RJ (2003) Lentiviral vectors for gene delivery to normal and demyelinated white matter. Glia 42(1):59–67. doi:10.1002/glia.10195 PubMedCrossRef

Title: Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS
Authors: Jigisha R. Patel
Jessica L. Williams
Megan M. Muccigrosso
Laindy Liu
Tao Sun
Joshua B. Rubin
Robyn S. Klein
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Acta Neuropathologica / Issue 6/2012
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI: https://doi.org/10.1007/s00401-012-1034-0

At a glance: The STEP trials

Springer Medicine

Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

The next step in brain tumor classification: “Let us now praise famous men”… or molecules?

[18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited

Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate

LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)

Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study